Clinical Efficacy of Dexlansoprazole vs Esomeprazole in Gastro-Oesophageal Reflux Disease: A Randomized Clinical Trial
Abstract
Background: Gastro-Esophageal reflux disease (GERD) is a very common problem in a gastrointestinal clinical setting. Still, the best treatment for it remains debatable as there are many new drugs that have evolved for its treatment in addition to dietary modification.Objective: To compare the clinical efficacy of Dexlansoprazole (modified-release 60 mg) and esomeprazole (40 mg) for the resolution of symptoms of GERD.Material and Methods: This randomized controlled trial or intervention was conducted for comparing the clinical efficacy of Dexlansoprazolevs Esomeprazole for the symptomatic treatment of GERD.A total of 100 endoscopically diagnosed patients were selected and were randomly allocated to two groups each containing 50 patients. Group 'A' contained 50 patients who were given 60 mg Dexlansoprazole for 2 weeks and group 'B' also contained the same number of patients receiving the treatment with Esomeprazole 40 mg for the same duration.After informed consent, a validated tool FSSG (Frequency Scale for the Symptoms of GERD) was used to collect the responses of patients. The Chi-square test was used to compare the responses of two groups considering a P-value of 0.05.Conclusion: This study concluded that the symptomatic relief of GERD after 2 weeks of therapy with Esomeprazole and Dexlansoprazole was the same except for dysphagia.Keywords: Dexlansoprazole, Esomeprazole,Gastroesophageal reflux disease.
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 100 participants or records.
Read the paper
Related studies
- Improving sleep quality leads to better mental health: A meta-analysis of randomised controlled trials
- Tocilizumab in patients with severe COVID-19: a retrospective cohort study
- A new aging measure captures morbidity and mortality risk across diverse subpopulations from NHANES IV: A cohort study
- Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study
- Are noise and air pollution related to the incidence of dementia? A cohort study in London, England
- Long COVID symptoms and duration in SARS-CoV-2 positive children — a nationwide cohort study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.